SCHEMBL19424940

SCHEMBL19424940

CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cccc4[nH]cnc34)cc2C)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19425023 0.94 — —
SCHEMBL19425054 0.94 BCL2 (0.74) —
SCHEMBL1955306 0.93 BCL2 (0.78) —
SCHEMBL1955310 0.93 BCL2 (0.78) —
SCHEMBL19424800 0.91 — —
SCHEMBL19424673 0.91 BCL2 (0.69) —
SCHEMBL19424509 0.91 BCL2 (0.69) —
SCHEMBL19425016 0.90 BCL2 (0.69) —
SCHEMBL19424810 0.89 BCL2 (0.70) —
SCHEMBL19424814 0.89 BCL2 (0.68) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10195213-B2 Chemical entities that kill senescent cells for use in treating age-related disease UNITY BIOTECHNOLOGY, INC. (US) 2019-02-05 — — US disclosed
US-20170281649-A1 COMPOUNDS AND THERAPEUTIC USES UNITY BIOTECHNOLOGY, INC. 2017-10-05 — — US disclosed
Send feedback